Premium

Serena Williams’ endorsement of weight-loss drug: A win for Big Pharma, a loss for patients

It could further legitimise the use of patient-ambassadors for private healthcare majors. That’s deeply concerning, particularly when the product is not a cough drop but a serious medication for obesity

Serena WilliamsAlthough the drugs are approved by the US Food and Drug Administration (FDA), their use should be bespoke and under medical supervision. (FILE photo)
Written by: Rinku Ghosh
5 min readAug 25, 2025 03:14 PM IST First published on: Aug 25, 2025 at 12:59 PM IST

Serena Williams is a textbook role-model — one of the greatest athletes in history, able to hold her own on and off the tennis court. But in her new role as brand ambassador for a healthcare company promoting blockbuster weight-loss drugs, she seems to have been co-opted by a larger narrative. The internet is abuzz with conversation about how someone known for her grit, whose achievements are so hard to emulate, appears to have succumbed to the pressure to be “thin” and endorse a deeply problematic message with the potential to influence the choices of millions.

A tough fighter from the word go, Williams has 23 tennis Grand Slam titles; her dominance of the sport even inspired the term “Serena Slam” in the tennis lexicon. She has shattered racial, gender and class barriers in tennis. On the French Open court, she once played in a black catsuit because it made her feel like a “warrior princess.”

Rinku Ghosh is the Health Section Lead at Read More

Latest Comment
Post Comment
Read Comments